Surgery Partners Beheer
Beheer criteriumcontroles 3/4
De CEO Surgery Partners is J. Evans, benoemd in Jan2020, heeft een ambtstermijn van 4.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 6.46M, bestaande uit 16.3% salaris en 83.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.36% van de aandelen van het bedrijf, ter waarde $ 10.35M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.8 jaar en 6.5 jaar.
Belangrijke informatie
J. Evans
Algemeen directeur
US$6.5m
Totale compensatie
| Percentage CEO-salaris | 16.3% |
| Dienstverband CEO | 4.8yrs |
| Eigendom CEO | 0.4% |
| Management gemiddelde ambtstermijn | 2.8yrs |
| Gemiddelde ambtstermijn bestuur | 6.5yrs |
Recente managementupdates
Recent updates
Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Nov 11
Market Cool On Surgery Partners, Inc.'s (NASDAQ:SGRY) Revenues
Oct 24Surgery Partners (NASDAQ:SGRY) Has Some Way To Go To Become A Multi-Bagger
Oct 05Surgery Partners, Inc. (NASDAQ:SGRY) Soars 25% But It's A Story Of Risk Vs Reward
Jul 25Here's Why Surgery Partners (NASDAQ:SGRY) Has A Meaningful Debt Burden
Jul 13Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement
Jun 21We Think Shareholders Are Less Likely To Approve A Pay Rise For Surgery Partners, Inc.'s (NASDAQ:SGRY) CEO For Now
May 31Surgery Partners, Inc.'s (NASDAQ:SGRY) Share Price Matching Investor Opinion
Apr 24Surgery Partners' (NASDAQ:SGRY) Returns Have Hit A Wall
Mar 18Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Feb 27The Price Is Right For Surgery Partners, Inc. (NASDAQ:SGRY)
Dec 19Returns Are Gaining Momentum At Surgery Partners (NASDAQ:SGRY)
Oct 26Does Surgery Partners (NASDAQ:SGRY) Have A Healthy Balance Sheet?
Sep 17Are Investors Undervaluing Surgery Partners, Inc. (NASDAQ:SGRY) By 35%?
Aug 26The Return Trends At Surgery Partners (NASDAQ:SGRY) Look Promising
Jul 21Surgery Partners, Inc.'s (NASDAQ:SGRY) Shareholders Might Be Looking For Exit
Jun 15A Look At The Intrinsic Value Of Surgery Partners, Inc. (NASDAQ:SGRY)
May 26There's Been No Shortage Of Growth Recently For Surgery Partners' (NASDAQ:SGRY) Returns On Capital
Apr 14Surgery Partners (NASDAQ:SGRY) Has A Somewhat Strained Balance Sheet
Mar 24Surgery Partners, Inc. (NASDAQ:SGRY) Shares Could Be 50% Below Their Intrinsic Value Estimate
Jan 24We Think Surgery Partners (NASDAQ:SGRY) Is Taking Some Risk With Its Debt
Sep 26The Returns On Capital At Surgery Partners (NASDAQ:SGRY) Don't Inspire Confidence
Aug 15Surgery Partners GAAP EPS of -$0.21 misses by $0.07, revenue of $615.4M misses by $3.61M
Aug 02Surgery Partners And Alternative Near Cap-Gain Portfolio Wealth Builders
Jul 02Surgery Partners (NASDAQ:SGRY) Takes On Some Risk With Its Use Of Debt
Jun 27Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$61m |
| Jun 30 2024 | n/a | n/a | -US$34m |
| Mar 31 2024 | n/a | n/a | US$600k |
| Dec 31 2023 | US$6m | US$1m | -US$12m |
| Sep 30 2023 | n/a | n/a | -US$34m |
| Jun 30 2023 | n/a | n/a | -US$54m |
| Mar 31 2023 | n/a | n/a | -US$92m |
| Dec 31 2022 | US$6m | US$1m | -US$55m |
| Sep 30 2022 | n/a | n/a | -US$31m |
| Jun 30 2022 | n/a | n/a | -US$29m |
| Mar 31 2022 | n/a | n/a | -US$38m |
| Dec 31 2021 | US$4m | US$1m | -US$81m |
| Sep 30 2021 | n/a | n/a | -US$86m |
| Jun 30 2021 | n/a | n/a | -US$135m |
| Mar 31 2021 | n/a | n/a | -US$150m |
| Dec 31 2020 | US$4m | US$916k | -US$156m |
| Sep 30 2020 | n/a | n/a | -US$179m |
| Jun 30 2020 | n/a | n/a | -US$132m |
| Mar 31 2020 | n/a | n/a | -US$119m |
| Dec 31 2019 | US$5m | US$435k | -US$110m |
Compensatie versus markt: De totale vergoeding ($USD 6.46M ) J. } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.60M ).
Compensatie versus inkomsten: De vergoeding van J. is gestegen terwijl het bedrijf verliesgevend is.
CEO
J. Evans (47 yo)
4.8yrs
Tenure
US$6,457,600
Compensatie
Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 6.8yrs | US$250.00k | 0.080% $ 2.3m | |
| CEO & Director | 4.8yrs | US$6.46m | 0.36% $ 10.3m | |
| Executive VP & CFO | 2.8yrs | US$3.52m | 0.076% $ 2.2m | |
| Executive VP and Chief Administrative & Development Officer | 4.8yrs | US$3.09m | 0.15% $ 4.1m | |
| Executive VP & Chief Strategy Officer | 2.8yrs | US$1.68m | 0.031% $ 895.3k | |
| Senior Vice President of Operations - Central Region | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of Corporate Finance & Controller | 2.5yrs | geen gegevens | geen gegevens | |
| Senior VP & Chief Information Officer | 3.3yrs | geen gegevens | geen gegevens | |
| Senior VP & Chief Compliance Officer | 6yrs | geen gegevens | geen gegevens | |
| General Counsel & Senior VP | less than a year | geen gegevens | geen gegevens | |
| Executive VP & Chief Human Resources Officer | 1.8yrs | geen gegevens | 0.024% $ 683.3k | |
| Chief Growth Officer | 5.3yrs | US$1.30m | 0.081% $ 2.3m |
2.8yrs
Gemiddelde duur
50yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van SGRY wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 6.8yrs | US$250.00k | 0.080% $ 2.3m | |
| CEO & Director | 4.8yrs | US$6.46m | 0.36% $ 10.3m | |
| Director | 7.1yrs | US$260.00k | 0.040% $ 1.1m | |
| Director | 3.5yrs | geen gegevens | geen gegevens | |
| Independent Director | 8.9yrs | US$285.00k | 0.054% $ 1.5m | |
| Independent Director | 3.8yrs | US$260.00k | 0.014% $ 398.9k | |
| Independent Director | 8.2yrs | US$280.00k | 0.046% $ 1.3m | |
| Independent Director | 5.5yrs | US$260.00k | 0.022% $ 616.5k | |
| Director | 7.3yrs | geen gegevens | geen gegevens | |
| Director | 6.3yrs | geen gegevens | geen gegevens |
6.5yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van SGRY wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).